News about Global Pharma

Eli Lilly's Omvoh Shows Long-Term Efficacy in Crohn's Disease: VIVID-2 Study Results Announced

Omvoh works to reduce inflammation within the gastrointestinal tract by targeting a specific protein, interleukin-23p19 (IL-23p19), which is a key contributor to intestinal inflammation.

Global Pharma | 07/02/2025 | By Abha |  543

Astellas Submits NDA for Conditional Approval of Avacincaptad Pegol for Geographic Atrophy in Japan

Astellas Pharma has submitted a New Drug Application in Japan for avacincaptad pegol (ACP), a potential first-in-class treatment for geographic atrophy (GA) secondary to AMD, aiming to address a major unmet medical need.

Global Pharma | 06/02/2025 | By Manvi |  250

Serplulimab Gains EU Approval for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer (ES-SCLC)

Shanghai Henlius Biotech's anti-PD-1 mAb, HANSIZHUANG (serplulimab), has received European Commission approval as the first and only anti-PD-1 therapy for first-line treatment of ES-SCLC, marking a major milestone in lung cancer treatment.

Global Pharma | 06/02/2025 | By Manvi |  717

AGC Pharma Chemicals Expands its HPAPI Capabilities in Barcelona

This strategic expansion in Barcelona addresses the growing demand for HPAPI driven by advances in oncology and targeted therapies, where highly potent compounds are essential for developing more precise and effective treatments.

Global Pharma | 06/02/2025 | By Aishwarya |  355

Indegene Unveils New Entity in Spain to Expand its Presence in Europe

Indegene’s new Spain entity will serve as a key delivery hub for its Europe-based clients, helping them drive hyper-personalization and significantly elevate HCP and patient experience.

Global Pharma | 06/02/2025 | By Aishwarya |  701

Thermo Fisher Scientific Signs VPPA with X-ELIO

Thermo Fisher’s 73 MW portion of the Lorca solar project will generate approximately 150,000 megawatt-hours of renewable electricity annually–equivalent to powering approximately 40,500 European homes for one year.

Global Pharma | 06/02/2025 | By Aishwarya |  334

Zydus Reports Robust Growth in Q3 FY25 with a 17 Percent Increase in Revenue

Zydus Lifesciences recorded revenue from operations at INR 52,691 million, marking a 17 percent increase year-over-year.

Global Pharma | 06/02/2025 | By Aishwarya |  1349

Takeda Names Julie Kim as Future CEO Amid Strategic Growth Plans

The appointment follows a multi-year succession process, and Kim will also be proposed as a candidate for election to the Board at Takeda’s Annual General Shareholders Meeting in June 2026.

Global Pharma | 05/02/2025 | By Aishwarya |  680

MITEM PHARMA Acquires FLISINT Speciality from Sanofi

MITEM PHARMA has set itself the task of making available to patients and medical staff essential medicines that have been taken off the market.

Global Pharma | 05/02/2025 | By Aishwarya |  299

Bhavin Mukund Mehta Joins Pharmexcil as its Vice-Chairman

Mehta, an industry veteran with over 25 years of experience, has been instrumental in expanding Kilitch Drugs’ presence in international markets while strengthening its foothold in India.

Global Pharma | 05/02/2025 | By Aishwarya |  687